Publications

Considering the contribution of metabolic dysfunction-associated steatotic liver disease to incident Advanced chronic liver disease in people living with HIV.

Comparing COVID-19 vaccine-induced antibody neutralization capacity in PLWH vs. HIV-negative individuals following two vaccine doses

Considering the prognosis of patients cured of HCV compared to the general population.

Considering the recruitment progression for the Canadian Co-infection Cohort

Investigating primary prevention strategies against cardiovascular disease in people living with HIV.

Looking at the treatment of porphyria cutanea tarda in a person living with HIV.

Examining the global prevalence of chronic pain in women with HIV

Examining the risk of hospitalization within 14 days of COVID-19 diagnosis among people living with HIV (PLWH) and HIV-negative individuals who had laboratory-confirmed SARS-CoV-2 infection.

Looking at bone mineral density in women living with HIV.

Considering the prevalence of HPgV in a cohort of HCV/HIV co-infected patients undergoing treatment for HCV with direct acting antivirals (DAA) and investigate the effect of DAA therapy on HPgV infection.